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The processes of diﬀerentiation, proliferation, and apoptosis were studied in a cell culture of human cortical thymocytes under
the inﬂuence of short peptides T-32 (Glu-Asp-Ala) and T-38 (Lys-Glu-Asp). Peptides T-32 and T-38 ampliﬁed cortical thymocytes
diﬀerentiation towards regulatory T cells, increased their proliferative activity, and decreased the level of apoptosis. Moreover,
peptides under study stimulated proliferative and antiapoptotic activity of the mature regulatory T cells.
1.Introduction
Being a major organ of the immune system, thymus plays
a key role in the T cell immunity formation [1, 2]. An
overt lowering of thymus functional activity in humans can
be traced from the beginning of puberty and is associated
with an early involution of this organ [3, 4]. Thymus
involution is largely manifested by the reduced count of
cortical thymocytes and mature T cells [1, 5]. Age-related
reduction of thymus functional activity is a main cause of
immunodeﬁciency, allergic reactions, respiratory infections,
and other pathologies associated with a malfunction of the
immune system [6, 7]. Therefore, the search of drugs able
to revitalize thymus activity in its involution stage is one of
the goals of immunology and gerontology [8–10]. The aim
of the study has been to estimate the impact of the synthetic
peptides on the diﬀerentiation of cortical thymocytes and
mature T cells.
2.MaterialsandMethods
The cultures of human embryo thymus cells (14–26 weeks of
gestation) were subject to investigation. They were studied in
the following stages of their diﬀerentiation: immature corti-
cal cells (CD4+CD8+) and mature regulatory T lymphocytes
(CD4+CD25+).
Culture samples were obtained from the Laboratory of
Cell Immunology of the Institute of the Federal Medical
and Biological Agency. 4 control, and 12 experimental
samples were incubated with synthetic peptides T-32 (Glu-
Asp-Ala) and T-38 (Lys-Glu-Asp) at a single dose of
200ng/mLforanhouratthetemperatureof37◦C.Theabove
peptides were designed at the Saint-Petersburg Institute of
Bioregulation and Gerontology of the Russian Academy
of Medical Sciences (Russia). They were synthesized on
the basis of amino acid sequences found in polypeptide
extracts from the cattle thymus and vessels. It was previously
determined that peptides T-32 and T-38 facilitated the
expression of diﬀerentiation markers of thymes epithelial
cells—proteins Pax1, Hoxa3, and TLP in cell culture. This
eﬀect was more pronounced in old cultures (8 passages)
than in young cultures (1 passage) [11]. Apart from that,
the inﬂuence of peptides T-32 and T-38 on stem CD34+
cells of the bone marrow was investigated. Peptide T-38
stimulated stem cells expression of myeloid cells marker
CD14andmarkerofB-cellsCD19inthebonemarrow,while
peptide T-32 stimulated the expression marker CD19 only
[11].
The functional activity of cells in the selected samples
was studied in respect to the expression of the proapoptotic
protein p53, antiapoptotic protein Mcl-1, and proliferation
factorKi-67.Thesamesamplesofthecellculturesunderwent2 Journal of Amino Acids
ultrastructural examination by means of transmitting elec-
tron microscopy and uranaﬃn reaction. Thymocyte cultures
in the selected stages of their diﬀerentiation were prepared
for further immunocytochemistry and electron microscopy
studies in the following order.
(1) Cell suspension was precipitated by centrifugation at
1000rpm for 3 minutes. The resulting sediment in
the quantity of 0,05–0,2mL was set to resuspension
in 3mL of the 2,5% solution of the glutaralaldehyde
on the 0,1M of phosphate buﬀer (pH = 7,4). In 5
minutes the suspension of cells was centrifuged at
1000rpm; the cells were rinsed with 0,1M phosphate
buﬀer for 2 minutes and then set to resuspension
again in 6mL of aldehyde ﬁxative. After that, the
content of each test was put into 2 tubes by 3mL of
suspension in each and ﬁxed for 30 minutes.
(2) The cells were rinsed with 0,1M of the phosphate
buﬀer 3 times for 10 minutes each time. At this stage,
the samples for electron microscopy were extra-ﬁxed
in 1% osmium tetroxide for 45 minutes.
(3) The cells for both studies were dehydrated by 70%
ethanol (3 times for 10 minutes each), and those
for electron microscopy were subject to additional
resuspension in 2% uranyl acetate for 12 hours.
(4) The samples were subsequently dehydrated by 96% and
100% ethanol, then with 100%a c e t o n e( 3t i m e sf o r
5 minutes each). Afterwards, the suspension of cells
was soaked in the mixture of acetone and epon (1:1)
for 1 hour.
(5) Onedropoftheeponmixturewasaddedtoeachplas-
tic capsule. The sediment of cells in the amount of
1mm 3 was placed into these plastic capsules and left
for 12 hours. Then the capsules were centrifuged at
1500rpm for 10 minutes to achieve cell precipitation
and then put into a thermostat at the temperature
of 56◦C for 48 hours. Semithin slices (1µm) and
ultrathin slices (70nm) were prepared on the ultra
microtome LKB-7A (LKB, Sweden).
For the immunocytochemical study, semithin slices were
stained with methylene blue-azure II main fuchsine. After-
wards, immunocytochemical method was undertaken with
application of monoclonal antibodies to p53 (1:150), Mcl-1
(1:500), Ki-67 (1:250), and the sets for the visualization of
the immunostaining (all the Novocastra reagents). Avidin-
biotinylated horseradish peroxidase complex for visualiza-
tionwasemployedwithsubsequentuseofdiaminobenzidine
(ABS-kit, Dako).
An immunocytochemical study was carried out in strict
accordance with a standard protocol.
Ultra-thin slices were used for electron microscopy. They
were contrasted with uranyl acetate and lead citrate. The
study was carried out on the electron microscope JEM-100S
(JEOL, Japan). For ultrastructural analysis, whole cells and
their fragments were photographed under the magniﬁcation
of 14,000.
Veriﬁcation of the secretory granules on the ultrastruc-
tural level was made using the uranaﬃn reaction. For this
purpose cell sediment was ﬁxed with 3% glutarate aldehyde
onthe0,1Mcacodylicbuﬀer(pH=7,2)for90minutes.After
that,1mmcutblockswererinsedwith0,9%sodiumchloride
solution 3 times for 15 minutes each. The rinsed blocks were
placed into 4% uranyl acetate water solution (pH = 3,9) at 4
◦C for 18 hours. After the rinsing was done, the blocks were
dehydrated in the alcohols and placed in epon.
An morphometric study was carried out using the
computer analysis system of microscopic images, which
consists of the Nikon Eclipse E400 microscope, digital
camera Nikon DXM1200, and an Intel Pentium 4 computer
with the “Morphology-Videotest 4.0” software installed on
it. In each case, 10 ﬁelds of vision were analyzed at the
magniﬁcation of 400. The surface of the expression was
estimated by counting the proportion of immune-positive
cells in the total area of the cells in the ﬁeld of vision. The
optical density of the expression was expressed in units. The
optical density is a nondimensional value characterized by
the level of light absorption. In our study, the optical density
was estimated by Vidiotest-Morphology 5.0 to ﬁnd out the
ability of cells to express the investigated markers. The term
“unit” in this paper is used to emphasize that the optical
density is a nondimensional value and can be taken out if
needed.
Cross-sectionalexpressionoftwomolecules—markersof
the thymocyte diﬀerentiation—was evaluated by a two-color
ﬂow cytometry method with application of monoclonal
antibodies to CD8, marked with ﬂuorescein thiocyanate
and the monoclonal antibodies to CD4, marked with phy-
coerytherin (Becton Dickinson, USA). In order to measure
the expression of antibodies, the cells were incubated with
the marked monoclonal antibodies at 37◦C for 30 minutes.
The binding of antibodies, marked with a ﬂuorochrome,
was monitored on the ﬂow cytometry reader FACSCalibur
(Becton Dickinson) with the help of the “CellQuest 3.1”
software. In each case, 10,000 cells were analyzed in the rays
oftheargonlaser(power—15mWt,wavelength—448nm)at
the speed of 6,000 cells per second.
The results of the experiment were put out to the EXCEL
(Microsoft)andSTATISTICA5.0(Statsoft).Forthepurposes
of measuring the mean, the Student’s t-criterion with the
d o u b l ev a l u eo f9 5 %w a su s e d .
3. Results of Investigation
Morphometric analysis has shown that the peptides under
study revealed a stimulating eﬀect on the proliferation of
the immature cortical cells (CD4+CD8+) and diﬀerentiated
regulatory T lymphocytes (CD4+CD25+).
The area of the expression and the optical density of the
proliferative marker Ki-67 on CD4+CD8+ membranes have
risen reliably by 75% and 12% correspondingly under the
inﬂuence of the peptide T-38, as compared to the control.
Peptide T-32 did not show the same eﬀect (Figure 1(a)).
At the same time, the eﬀect of the peptides on the
diﬀerentiation of CD4+CD25+ was more pronounced asJournal of Amino Acids 3
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Figure 1: Expression of the marker of proliferation (Ki-67), apoptosis (p53) and antiapoptotic protein Mcl identiﬁed by immunocytochem-
ical analysis in subpopulations of CD4+CD8+ and CD4+CD25+. ∗P<0,05 as compared to the control group. S—area of the expression
(%), P—optical density of the expression (units).
compared to immature cortical cells. The area of the
expression of the Ki-67 on the surface of the regulatory T
lymphocytes under the action of both peptides under study
has risen 2-2,3-fold, and the optical density was 1,7-2-fold in
comparison with the control (Figure 1(b)).
Apartfromthat,peptidesT-32andT-38preventedapop-
tosis of the diﬀerentiated and nondiﬀerentiated thymocytes
through the reduction of the expression of the proapoptotic
protein p53 as well as through the increase in the level of the
antiapoptotic protein Mcl.
The area of expression and the optical density of p53
have reduced approximately 2-fold under the inﬂuence of
T-32 and T-38 on the CD4+CD8+ cells in comparison with
the control (Figure 1(c)), whilst the area of the expression of
the antiapoptotic marker Mcl has risen 1,4-1,5-fold after the
incubation of the cortical thymocytes with the peptides. The4 Journal of Amino Acids
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Figure 2: The eﬀect of peptide T-38 on the proliferation of thymocytes, ×14,000: (a) proliferation of immature cortical cells (CD4+CD8+),
(b) dividing regulatory T-lymphocyte (CD4+CD25+) in the metaphase stage.
peptides did not aﬀect the optical density of the expression
of Mcl CD4+CD8+ cells (Figure 1(c)).
Mature CD4+CD25+ cells appeared less sensitive to the
antiapoptotic action of T-38 in comparison with the cortical
thymocytes. So, the area of the expression of p53 did not
change under the inﬂuence of T-38 and the optical density
decreased only 1,3-fold (Figure 1(d)). When T-32 was added
to the CD4+CD25+ cell culture, the area of the expression
and the optical density of p53 reduced 2- and 2,2-fold,
correspondingly in relation to the control (Figure 1(d)).
Both of the studied peptides contributed to the 1,5-fold
increase in the area of the expression of the antiapoptotic
factor Mcl, both in cortical thymocytes, and T-regulatory
lymphocytes, as compared to the control (Figures 1(d) and
1(e)). However the optical density of the expression of
the above-mentioned marker did not change reliably in
the CD4+CD8+ cells under the inﬂuence of peptides T-32
and T-38, but did increase 1,3-fold in the diﬀerentiated T-
regulatory cells (Figures 1(d) and 1(e)).
The data obtained were conﬁrmed by electron micro-
scopy results. Peptides T-32 and T-38 promoted the increase
in the quantity of mitosis ﬁgures amongst sliced and
singularly placed cortical cells (Figure 2(a)). The ultrastruc-
ture of the cortical thymocytes was characterized by the
weakly developed layer complex, and large quantity of the
mitochondria and ribosomes localized close to the nuclei.
A large quantity of cells which entered mitosis was reg-
istered under the inﬂuence of both peptides in the or-
ganotypic layers formed by the regulatory T lymphocytes
(Figure 3(b)). Heterochromatin density increased in the
nuclei of the regulatory T cells that are a part of the cells
layers. Cytoplasm of the mature thymocytes manifested an
increase in the quantity of endoplasmic reticulum and the
complex layered elements following the administration of
T-32 and T-38 peptides. This fact points at the intensiﬁed
secretory functions of cells.
Indirect immunocytochemistry data which suggested
possible T-32, and T-38—mediated stimulation of the
cortical CD4+CD8+ thymocytes diﬀerentiation in the T-
regulatory cells with phenotype CD4+CD8- was conﬁrmed
by the results of the ﬂow cytometry. The quantity of
CD4+CD8- cells made 4,3% in the control culture of
the thymocytes with the total number of double positive
CD4+CD8+ thymocytes—90,6%. The number of diﬀeren-
tiated CD4+CD8- cells rose up to 13,7%, and the number of
the double positive thymocytes went down to 79,7% under
the eﬀect of peptide T-38 (Figures 3(a) and 3(b)).
4. Discussion
Immunocytochemistry data evidence the ability of peptides
T-32 and T-38 to induce diﬀerentiation of the cortical thy-
mocytes in the direction of T-regulatory cells. The peptides
facilitate proliferative activity, decrease the level of apoptosis,
and increase the expression of antiapoptotic factors. The
eﬀect of peptide T-32 in its most is shown through its eﬀect
on the mature CD4+CD25+ cells. The action of T-38 was
mostly targeted at the immature CD4+CD8+ thymocytes.
Electron microscopy and cytometry studies conﬁrmed the
results received by the method of immunocytochemistry and
pointed at the fact that synthetic peptides T-32 and T-38 are
eﬀective stimulators of diﬀerentiation and proliferation as
well as inhibitors of thymocytes’ apoptosis on diﬀerent levels
of their development.
The obtained results cohere with the experimental data
which revealed a stimulating eﬀect of the synthetic peptides
of thymus and epiphysis on the diﬀerentiation of the
polypotent cells [3, 6]. The retina peptides were shown
earlier to stimulate proliferative activity of the pigmented
epithelium [3]. The experimental results obtained and the
literature data available suggest that the peptide regulation is
based on the ability of peptides to stimulate the proliferativeJournal of Amino Acids 5
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Figure 3: The proportion of CD4+CD8+ and CD4+CD8- thymocytes. (a) thymocytes control culture. (b) thymocytes culture with peptide
T-38. CD4+ cells-two upper quadrants; CD8+ cells-two quadrants on the right.
activity and diﬀerentiation of cells. It is worth mentioning
that the given eﬀects in diﬀerent tissues are achieved only
under the action of speciﬁc peptides.
5. Conclusion
The results of investigation evidence the property of peptide
bioregulators to promote the enhanced functional activity of
the thymus. Synthetic peptides reveal tissue-speciﬁc mecha-
nism of action and targeted stimulation of cells, proliferative
activity and diﬀerentiation.
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